Fecal and Serum Metabolomic Signatures and Microbial Community Profiling of Postmenopausal Osteoporosis Mice Model

Kaicheng Wen, Lin Tao, Zhengbo Tao, Yan Meng, Siming Zhou, Jianhua Chen, Keda Yang, Wacili Da, Yue ZhuFrontiers in Cellular and Infection Microbiology 2020 · DOI

TL;DR

This study reveals a significant link between gut microbiota composition, fecal and serum metabolite profiles, and the development of postmenopausal osteoporosis in mice. The findings suggest a "microbiota-gut-metabolite-bone" axis plays a crucial role in osteoporosis pathogenesis, identifying potential biomarkers for future research and intervention.

What Problem Does This Paper Address?

Postmenopausal osteoporosis (OP) is a major health concern for women worldwide, characterized by decreased bone density and increased fracture risk due to hormonal changes. While the gut microbiota is known to influence bone metabolism, its specific role in postmenopausal OP remains unclear. Existing treatments are not always fully effective, highlighting the need for a deeper understanding of OP's underlying mechanisms. This paper aims to elucidate the relationship between gut microbiota, metabolites, and postmenopausal osteoporosis by investigating how changes in the gut environment contribute to the disease.

Methods

The researchers employed a multi-omics approach to investigate the complex interplay between the gut microbiome and osteoporosis.

  • Mouse Model: A postmenopausal osteoporosis mouse model was created by ovariectomizing female mice.
  • Bone Structure Analysis: Micro computed tomography (Micro CT) was used to assess bone volume, structure, and density in both control and OP groups.
  • Microbial Community Profiling: 16S rRNA gene sequencing was performed on fecal samples to analyze the composition and diversity of the gut microbiota.
  • Metabolomic Analysis: Ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS) was utilized to identify and quantify metabolites in both fecal and serum samples.
  • Network Analysis: Correlation networks were constructed to explore the relationships between specific gut microbial genera and identified metabolites.
  • Machine Learning for Classification: Random Forest analysis was applied to assess the effectiveness of the combined fecal and serum metabolomic data and microbial profiles in distinguishing between OP and control groups.

Datasets

The study utilized data generated from experiments on a postmenopausal osteoporosis mouse model. No external datasets were explicitly mentioned for training or evaluation. The raw data from this study is publicly available via the NCBI database (PRJNA607414).

Key Insights and Ideas

  • Gut Microbiota Imbalance in OP: The study found significant differences in gut microbiota composition between the OP and control groups, with an increased Firmicutes/Bacteroidetes ratio and reduced Verrucomicrobia in the OP mice.
  • Metabolite Signatures of OP: Distinct patterns of upregulated and downregulated metabolites were observed in both feces and serum of OP mice compared to controls.
  • Bile Acids as Key Players: A notable finding was the significant difference in specific bile acids between the groups, suggesting their involvement in OP pathogenesis. These bile acids showed a strong correlation with the bacterial family Eggerthellaceae.
  • "Microbiota-Gut-Metabolite-Bone" Axis: The research strongly suggests that the gut microbiota and its metabolites are not just associated with, but actively contribute to the development of postmenopausal osteoporosis through a complex axis.
  • Potential Biomarkers Identified: The study identified specific metabolites and microbial signatures that could serve as potential biomarkers for early detection or therapeutic targeting of postmenopausal osteoporosis.
  • Machine Learning Validation: Random Forest analysis demonstrated a high accuracy (AUC of 0.99) in distinguishing OP mice from controls based on the combined microbial and metabolomic data, validating the robustness of the findings.

Key Results

  • Micro CT analysis revealed reduced bone volume percentage (BV/TV), cortical volume (Ct.V), cortical thickness (Ct.Th), and trabecular number (Tb.N) in OP mice compared to controls.
  • 16S rRNA sequencing identified significant shifts in gut microbial composition, including an increased Firmicutes/Bacteroidetes ratio and a decrease in Verrucomicrobia in the OP group.
  • Metabolomic analysis identified 53 upregulated and 61 downregulated metabolites in feces, and 2 upregulated and 22 downregulated metabolites in serum of OP mice.
  • Network analysis highlighted strong correlations between specific bile acids (e.g., hydrodeoxycholic acid, glycocholic acid, deoxycholic acid) and bacterial genera like Gordonibacter and Parvibacter, which belong to the Eggerthellaceae family.
  • Random Forest analysis achieved an AUC of 0.99 for both fecal and serum data in distinguishing OP from control groups.

Limitations and Future Work

The authors acknowledge several limitations:

  • Small Sample Size: The study's sample size was relatively small, which may limit the generalizability of the findings, particularly for the random forest analysis.
  • Correlation vs. Causation: While strong correlations were found between the gut microbiota, metabolites, and osteoporosis, the study design does not definitively prove a causal relationship.

Future work should focus on:

  • Larger Sample Size Studies: Conducting experiments with larger sample sizes to further validate the findings and identify robust biomarkers.
  • Mechanistic Studies: Investigating the precise causal mechanisms by which specific gut microbes and their metabolites influence bone metabolism and osteoporosis development.
  • Therapeutic Interventions: Exploring the potential of targeting the gut microbiota or its metabolites as a therapeutic strategy for preventing or treating postmenopausal osteoporosis.

Summary updated

Abstract

These results indicated that changes in the gut microbiota and metabolites in feces and serum were responsible for the occurrence and development of postmenopausal osteoporosis. The gut microbiota is a vital inducer of osteoporosis and could regulate the pathogenesis process through the "microbiota-gut-metabolite-bone" axis, and some components of this axis are potential biomarkers, providing a new entry point for the future study on the pathogenesis of postmenopausal osteoporosis.
BibTeX
@inproceedings{wen2020fecal,
  author = {Kaicheng Wen and Lin Tao and Zhengbo Tao and Yan Meng and Siming Zhou and Jianhua Chen and Keda Yang and Wacili Da and Yue Zhu},
  title = {{Fecal and Serum Metabolomic Signatures and Microbial Community Profiling of Postmenopausal Osteoporosis Mice Model}},
  booktitle = {Frontiers in Cellular and Infection Microbiology},
  year = {2020},
  doi = {10.3389/fcimb.2020.535310},
}
Figure